A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
Public ClinicalTrials.gov record NCT07095452. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 2/3, Multicenter, Randomized, Open-Label Study Evaluating the Efficacy and Safety of Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Subjects With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
Study identification
- NCT ID
- NCT07095452
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Lead sponsor
- AbbVie
- Industry
- Enrollment
- 660 participants
Conditions and interventions
Conditions
Interventions
- Daratumumab Drug
- Dexamethasone Drug
- Etentamig Drug
- Lenalidomide Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 7, 2026
- Primary completion
- Dec 31, 2041
- Completion
- Dec 31, 2041
- Last update posted
- Apr 15, 2026
2026 – 2042
United States locations
- U.S. sites
- 13
- U.S. states
- 10
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mayo Clinic Hospital Scottsdale /ID# 278349 | Scottsdale | Arizona | 85259 | Recruiting |
| Colorado Blood Cancer Institute /ID# 279080 | Denver | Colorado | 80218 | Recruiting |
| Fort Wayne Medical Oncology And Hematology /ID# 278141 | Fort Wayne | Indiana | 46804 | Recruiting |
| Minnesota Oncology - Minneapolis Clinic /ID# 278720 | Minneapolis | Minnesota | 55404 | Recruiting |
| Mayo Clinic Hospital Rochester /ID# 277886 | Rochester | Minnesota | 55905 | Recruiting |
| Memorial Sloan Kettering Cancer Center - New York - York Avenue /ID# 277946 | New York | New York | 10065 | Recruiting |
| University of North Carolina at Chapel Hill /ID# 277708 | Chapel Hill | North Carolina | 27514 | Recruiting |
| Willamette Valley Cancer Institute and Research Center /ID# 278721 | Eugene | Oregon | 97401 | Recruiting |
| SCRI Oncology Partners /ID# 278353 | Nashville | Tennessee | 37203 | Recruiting |
| Texas Oncology - The Woodlands /ID# 278726 | The Woodlands | Texas | 77380 | Recruiting |
| Texas Oncology - Northeast Texas /ID# 278725 | Tyler | Texas | 75702 | Recruiting |
| Virginia Cancer Specialists - Fairfax /ID# 278716 | Fairfax | Virginia | 22031 | Recruiting |
| Blue Ridge Cancer Care - Roanoke /ID# 278722 | Roanoke | Virginia | 24014 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 25 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07095452, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 15, 2026 · Synced May 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07095452 live on ClinicalTrials.gov.